Shares of Altimmune Inc. are down more than 23% this year, but that has not deterred retail investors from losing hope in the ...
Shares of Altimmune (NASDAQ:ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors on ...
Shares of Altimmune (NASDAQ:ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors on Wall Street a day after issuing notable updates on its lead candidate ...